|
시장보고서
상품코드
2055272
세포 신호 전달 시장 : 제품 유형별, 신호전달 유형별, 신호전달 채널별, 기술별, 용도별, 최종사용자별, 지역별Cell Signaling Market, By Product, By Signaling Type, By Signaling Pathway, By Technology By Application, By End User, By Region |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
세포 신호 전달 시장은 2026년 66억 달러로 추정되고, 2033년에 110억 9,000만 달러에 이를 것으로 예상되고 있습니다. 또한, 2026-2033년 CAGR 7.8%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 66억 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 7.80% | 2033년 시장 규모 예측 : | 110억 9,000만 달러 |
세계 세포 신호 전달 시장은 생명공학 및 의료 연구 분야에서 매우 중요한 역할을 수행하는 급속히 발전하고 있는 분야입니다. 신호 전달(신호전달)이란 세포의 증식, 분화, 대사, 세포사멸(아포토시스) 등 다양한 세포 활동을 조절하는 복잡한 의사소통 과정을 의미합니다. 이 신호 전달 경로의 복잡한 네트워크에는 세포 표면에서 세포핵으로의 신호 전달이 포함되며, 이는 특정 세포 반응을 유발합니다. 세포 신호 전달 시장은 이러한 신호전달 경로의 연구 및 조작에 사용되는 시약, 분석 키트, 장비, 소프트웨어 등 광범위한 제품과 기술을 아우르고 있습니다. 만성 질환 유병률 증가와 맞춤형 의료에 대한 수요 증가에 따라, 세포 신호 전달 시장은 향후 몇 년 동안 큰 성장이 예상됩니다.
시장 역학
세계 세포 신호 전달 시장은 비정상적인 세포 신호 전달 경로와 관련된 암, 당뇨병, 심혈관 질환 등 만성 질환의 발병률 증가 등 여러 요인에 의해 성장하고 있습니다. 표적 치료 및 맞춤형 의료에 대한 수요 증가 또한 이 시장의 성장을 더욱 촉진하고 있습니다. 이는 세포 신호 전달 연구가 새로운 치료 표적의 규명 및 표적 치료제 개발에서 매우 중요한 역할을 하고 있기 때문입니다. 또한, 세포 생물학 분야의 연구 개발 활동에 대한 관심이 높아지고, 정부 및 민간 기관의 자금 지원이 증가함에 따라 시장 성장이 가속화될 것으로 예측됩니다. 그러나 세포 신호 전달 관련 제품 및 기술의 높은 비용과 숙련된 전문 인력의 부족이 시장 성장을 어느 정도 저해할 가능성이 있습니다. 또한, 신약 개발 및 개발 과정에 대한 엄격한 규제 요건이 시장 진출기업들에게 과제가 될 수 있습니다. 이러한 제약이 있음에도 불구하고, 세포 신호 전달 시장에는 큰 성장 기회가 존재합니다. 특히 신흥국에서는 의료비 증가와 첨단 의료 기술에 대한 인식 제고가 시장 확대를 이끌 것으로 예측됩니다.
본 조사의 주요 특징:
- 본 조사에서는 각 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 매개변수를 바탕으로 전 세계 세포 신호 전달 시장의 주요 기업 프로파일을 작성하였습니다. 구체적으로는 기업의 주요 성과, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략입니다.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 전 세계 세포 신호 전달 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 분석가 등 이 산업의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 세포 신호 전달 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 수월하게 내릴 수 있습니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 세포 신호 전달 시장 : 제품별, 2021-2033년
제5장 세계의 세포 신호 전달 시장 : 신호전달 유형별, 2021-2033년
제6장 세계의 세포 신호 전달 시장 : 신호전달 채널별, 2021-2033년
제7장 세계의 세포 신호 전달 시장 : 기술별, 2021-2033년
제8장 세계의 세포 신호 전달 시장 : 용도별, 2021-2033년
제9장 세계의 세포 신호 전달 시장 : 최종사용자별, 2021-2033년
제10장 세계의 세포 신호 전달 시장 : 지역별, 2021-2033년
제11장 경쟁 구도
제12장 애널리스트의 제안
제13장 참고 문헌과 조사 방법
LSH 26.06.23Cell Signaling Market is estimated to be valued at USD 6.60 Bn in 2026 and is expected to reach USD 11.09 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.8% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 6.60 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 7.80% | 2033 Value Projection: | USD 11.09 Bn |
The global cell signaling market is a rapidly evolving sector that plays a crucial role in the field of biotechnology and medical research. Cell signaling, also known as signal transduction, refers to the complex communication process that governs various cellular activities, such as cell growth, differentiation, metabolism, and apoptosis. This intricate network of signaling pathways involves the transmission of signals from the cell surface to the nucleus, triggering specific cellular responses. The cell signaling market encompasses a wide range of products and technologies, including reagents, assay kits, instruments, and software, which are used to study and manipulate these signaling pathways. With the increasing prevalence of chronic diseases and the growing demand for personalized medicine, the cell signaling market is poised for significant growth in the coming years.
Market Dynamics:
The global cell signaling market is driven by several factors, including the rising incidence of chronic diseases such as cancer, diabetes, and cardiovascular disorders, which are associated with aberrant cell signaling pathways. The increasing demand for targeted therapies and personalized medicine has further fueled the growth of this market, as cell signaling research plays a vital role in identifying novel drug targets and developing targeted therapeutics. Moreover, the growing focus on research and development activities in the field of cell biology, coupled with the increasing funding from government and private organizations, is expected to propel the market growth. However, the high cost of cell signaling products and technologies, along with the lack of skilled professionals, may hinder the market growth to some extent. Additionally, the stringent regulatory requirements for drug discovery and development processes may pose challenges to market players. Despite these restraints, the cell signaling market presents significant opportunities for growth, particularly in emerging economies, where the increasing healthcare expenditure and growing awareness about advanced medical technologies are expected to drive the market expansion.
Key Features of the Study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global cell signaling market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Thermo Fisher Scientific, Merck KGaA, Bio-Rad Laboratories, GE Healthcare, Roche Diagnostics, Sigma-Aldrich (part of Merck Group), Abcam, PerkinElmer, Becton, Dickinson and Company, Agilent Technologies, Promega Corporation, Cell Signaling Technology, QIAGEN, MilliporeSigma, and Takara Bio
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global cell signaling market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell signaling market
Market Segmentation
- Product Insights (Revenue, USD Bn, 2021 - 2033)
- Consumables
- Instruments
- Signaling Type Insights (Revenue, USD Bn, 2021 - 2033)
- Intracrine ligands
- Autocrine ligands
- Juxtacrine ligand
- Paracrine ligands
- Endocrine ligands
- Signaling Pathway Insights (Revenue, USD Bn, 2021 - 2033)
- MAPK/ERK Pathway
- PI3K/Akt Pathway
- Wnt Pathway
- Notch Signaling Pathway
- NF-kB Pathway
- JAK/STAT Pathway
- TGF-β Pathway
- Calcium Signaling Pathway
- Technology Insights (Revenue, USD Bn, 2021 - 2033)
- Microscopy
- Flow Cytometry
- Western Blotting
- ELISA
- Mass Spectrometry
- Immunohistochemistry
- Others
- Application Insights (Revenue, USD Bn, 2021 - 2033)
- Cancer Research
- Immunology
- Neuroscience
- Cardiovascular Research
- Stem Cell Research,
- Others (Metabolic disorders, etc.)
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Pharmaceutical and Biotechnology Companies
- Academic Research Institutions
- Hospitals and Clinical Laboratories
- Government Agencies
- Contract Research Organizations
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Thermo Fisher Scientific
- Merck KGaA
- Bio-Rad Laboratories
- GE Healthcare
- Roche Diagnostics
- Sigma-Aldrich (part of Merck Group)
- Abcam
- PerkinElmer
- Becton, Dickinson and Company
- Agilent Technologies
- Promega Corporation
- Cell Signaling Technology
- QIAGEN
- MilliporeSigma
- Takara Bio
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Cell Signaling Market, By Product
- Global Cell Signaling Market, By Signaling Type
- Global Cell Signaling Market, By Signaling Pathway
- Global Cell Signaling Market, By Technology
- Global Cell Signaling Market, By Application
- Global Cell Signaling Market, By End User
- Global Cell Signaling Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Cell Signaling Market, By Product, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Consumables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Instruments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global Cell Signaling Market, By Signaling Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Intracrine ligands
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Autocrine ligands
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Juxtacrine ligand
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Paracrine ligands
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Endocrine ligands
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Cell Signaling Market, By Signaling Pathway, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- MAPK/ERK Pathway
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- PI3K/Akt Pathway
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Wnt Pathway
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Notch Signaling Pathway
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- NF-kB Pathway
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- JAK/STAT Pathway
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- TGF-β Pathway
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Calcium Signaling Pathway
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Cell Signaling Market, By Technology, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Microscopy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Flow Cytometry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Western Blotting
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- ELISA
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Mass Spectrometry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Immunohistochemistry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Cell Signaling Market, By Application, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Cancer Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Immunology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Neuroscience
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Cardiovascular Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Stem Cell Research,
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others (Metabolic disorders, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
9. Global Cell Signaling Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Academic Research Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Hospitals and Clinical Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Government Agencies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Contract Research Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
10. Global Cell Signaling Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Signaling Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Signaling Pathway, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Signaling Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Signaling Pathway, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Signaling Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Signaling Pathway, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Signaling Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Signaling Pathway, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Signaling Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Signaling Pathway, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Signaling Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Signaling Pathway, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
11. Competitive Landscape
- Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck KGaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bio-Rad Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GE Healthcare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Roche Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sigma-Aldrich (part of Merck Group)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abcam
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- PerkinElmer
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Becton, Dickinson and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Agilent Technologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Promega Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cell Signaling Technology
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- QIAGEN
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- MilliporeSigma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Takara Bio
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
12. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
13. References and Research Methodology
- References
- Research Methodology
- About us
